Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.28B |
| 2 |
Apple
AAPL
|
+$1.23B |
| 3 |
Broadcom
AVGO
|
+$682M |
| 4 |
Amazon
AMZN
|
+$629M |
| 5 |
Palo Alto Networks
PANW
|
+$595M |
Top Sells
| 1 |
Procter & Gamble
PG
|
+$247M |
| 2 |
Cadence Design Systems
CDNS
|
+$160M |
| 3 |
O'Reilly Automotive
ORLY
|
+$155M |
| 4 |
Synopsys
SNPS
|
+$145M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$135M |
Sector Composition
| 1 | Technology | 28.26% |
| 2 | Healthcare | 13.33% |
| 3 | Financials | 12.08% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3551
Tourmaline Bio
TRML
$1.22B
| $633K | ﹤0.01% |
20,810
-20,001
| -49% | -$608K |
|
|
GAN
3552
DELISTED
GAN Ltd
GAN
| $632K | ﹤0.01% |
385,450
-22,150
| -5% | -$36.3K |
|
|
PEPL
3553
DELISTED
PepperLime Health Acquisition Corporation Class A Ordinary Share
PEPL
| $630K | ﹤0.01% |
60,360
+532
| +0.9% | +$5.55K |
|
|
TESS
3554
DELISTED
Tessco Technologies Inc
TESS
| $628K | ﹤0.01% |
70,179
+8,095
| +13% | +$72.5K |
|
3555
Comstock Holding Companies
CHCI
$186M
| $628K | ﹤0.01% |
149,823
+1,330
| +0.9% | +$5.57K |
|
|
MDWT
3556
DELISTED
Midwest Holding Inc. Common Stock
MDWT
| $627K | ﹤0.01% |
23,406
+7,594
| +48% | +$203K |
|
3557
PharmaCyte Biotech
PMCB
$6.86M
| $627K | ﹤0.01% |
219,074
+43,810
| +25% | +$125K |
|
3558
Innoviz Technologies
INVZ
$347M
| $623K | ﹤0.01% |
219,293
+665
| +0.3% | +$1.89K |
|
3559
Pyxis Oncology
PYXS
$116M
| $622K | ﹤0.01% |
242,787
+3,436
| +1% | +$8.8K |
|
3560
Gain Therapeutics
GANX
$62.2M
| $621K | ﹤0.01% |
138,721
+44,514
| +47% | +$199K |
|
|
ENZ
3561
DELISTED
Enzo Biochem, Inc.
ENZ
| $621K | ﹤0.01% |
337,575
-17,467
| -5% | -$32.1K |
|
|
VCSA
3562
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
| $621K | ﹤0.01% |
45,764
-54,945
| -55% | -$746K |
|
3563
STRATTEC Security
STRT
$280M
| $618K | ﹤0.01% |
33,941
| – | – |
|
3564
LINKBANCORP
LNKB
$270M
| $614K | ﹤0.01% |
102,351
+22,989
| +29% | +$138K |
|
|
SCX
3565
DELISTED
The L.S. Starrett Company
SCX
| $612K | ﹤0.01% |
58,545
| – | – |
|
3566
Lyra Therapeutics
LYRA
$10.5M
| $612K | ﹤0.01% |
2,977
| – | – |
|
3567
Celestica
CLS
$29.1B
| $611K | ﹤0.01% |
41,263
+128
| +0.3% | +$1.9K |
|
3568
Inter&Co
INTR
$3.87B
| $607K | ﹤0.01% |
193,963
+48,969
| +34% | +$153K |
|
3569
United Bancorp
UBCP
$84.8M
| $603K | ﹤0.01% |
50,466
| – | – |
|
3570
Ituran Location and Control
ITRN
$678M
| $600K | ﹤0.01% |
25,723
+801
| +3% | +$18.7K |
|
3571
Torrid Holdings
CURV
$179M
| $600K | ﹤0.01% |
213,410
-13,879
| -6% | -$39K |
|
3572
BigBear.ai
BBAI
$1.75B
| $600K | ﹤0.01% |
+255,145
| New | +$600K |
|
|
COOL
3573
DELISTED
Corner Growth Acquisition Corp. Class A Ordinary Shares
COOL
| $599K | ﹤0.01% |
56,198
| – | – |
|
|
WKME
3574
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $594K | ﹤0.01% |
61,924
+12,066
| +24% | +$116K |
|
3575
GH Research
GHRS
$800M
| $594K | ﹤0.01% |
50,029
+209
| +0.4% | +$2.48K |
|